Zinc Supplementation on Cellular Immunity in Thalassemia Major

Summary

Randomized controlled trial was conducted in post-splenectomy patients aged \>12 years. Subjects are randomly assigned to two groups (zinc and placebo). 1.5 mg/kg/day (max 50 mg/day) of Zinc is administered.

Timeline

Start

2013-09-01

Primary completion

2014-02-01

Completion

2014-02-01

Drugs

Indications